What is Advanced Bifurcation Systems?
Headquartered in Los Angeles, California, Advanced Bifurcation Systems operates at the intersection of medical engineering and clinical cardiology. The company specializes in the development of advanced stenting platforms designed specifically for the bifurcation of coronary arteries—a notoriously difficult area for traditional interventional procedures. By providing a paradigm shift in how clinicians approach left main heart disease, the company has carved out a distinct niche in the medical technology market. Its platform is engineered to improve patient outcomes by offering precision tools that simplify complex procedures, thereby reducing the risks associated with traditional stenting methods in high-stakes cardiac interventions.
How much funding has Advanced Bifurcation Systems raised?
Advanced Bifurcation Systems has raised a total of $31.8M across 2 funding rounds:
Series A
$11M
Debt
$20.8M
Series A (2020): $11M with participation from Cedars-Sinai
Debt (2025): $20.8M, investors not publicly disclosed
Key Investors in Advanced Bifurcation Systems
Cedars-Sinai
A world-renowned non-profit academic medical center based in Los Angeles, specializing in complex clinical programs and advanced medical research.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Advanced Bifurcation Systems?
With the recent influx of capital, Advanced Bifurcation Systems is expected to prioritize the scaling of its manufacturing capabilities and the expansion of its clinical trial programs. The strategic focus will likely shift toward securing broader regulatory approvals and enhancing market penetration for its core stenting platform. As the company moves beyond its initial development phases, the management team is tasked with navigating the complexities of the global healthcare market, ensuring that their disruptive technology becomes a standard of care in interventional cardiology. Future growth will be contingent upon the successful integration of their devices into major hospital networks and the continued validation of their clinical efficacy through peer-reviewed research and long-term patient outcome studies.
See full Advanced Bifurcation Systems company page
